Skip to main content

Puri Michal Nath's Form 4 filing

NovoCure LtdNVCR · filed Nov 4, 2026

Accession no.
0001997032-26-000009
Filed
Nov 4, 2026, 4:05 PM ET
Trade date
Nov 2, 2026
Filing delay
2 days
Rule 10b5-1 plan
Not checked

This filing lists 1 non-derivative transaction. Open-market sales total $8.74K. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Puri Michal NathCIK 0001997032Officer (Chief Human Resources Officer)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Nov 2, 2026Ordinary SharesSSaleDisposed−660$13.24F2−$8,737.81202,567Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F2

This transaction was executed in multiple trades at prices ranging from $13.08 USD to $13.36 USD; the price reported above reflects the weighted average sale price.

Referenced by the price of 1 transaction in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)